Order Center
Product Name or No.
Keyword (Full Text)
MISSION shRNA-RNAi
MISSION siRNA
Molecular Formula
CAS No.
MDL No.
MSDS (Prod. No. Only)
Supplier X Reference
SubStructure
YFG Search
Product Catalog
→
Cell Biology
→
Cell Signaling and Neuroscience
→
Apoptosis and Cell Cycle
→ Apoptosis Inhibitors
Print Preview
Apoptosis Inhibitors
Scroll Up
Scroll Down
Reset Table
Image
Description
Biochem/physiol Actions
solubility
Product #
10058-F4 ≥98% (HPLC), solid
10058-F4 is a c-Myc inhibitor that induces cell-cycle arrest and apoptosis. It is a cell-permeable thiazolidinone that specificallly inhibits the c-Myc-Max interaction and prevents transactivation of c-Myc target gene expression. 10058-F4 inhibits tumor cell growth in a c-Myc-dependent manner both
in vitro
and
in vivo
(64 mM using c-Myc transfected Rat1a fibroblasts).
DMSO: >10 mg/mL
H
2
O: <2 mg/mL
F3680
BAX Inhibiting Peptide V5 ≥97% (HPLC), lyophilized powder
Bax-mediated apoptosis inhibitor; membrane permeable pentapeptide based on the Ku70-Bax inhibiting domain.
B1436
BBMP ≥98% (HPLC), solid
BBMP is a mitochondrial permeability transition pore (PTP) inhibitor. PTP inhibitors and mitochondrial depolarization are potential therapeutics for neurodegenerative diseases.
DMSO: 16 mg/mL
H
2
O: <2 mg/mL
B7936
BI-6C9 ≥97% (HPLC), solid
BI-6C9 is a tBid inhibitor and antiapoptotic.
DMSO: 24 mg/mL
H
2
O: insoluble
B0186
Bongkrekic acid solution from
Pseudomonas cocovenenans
, ≥95% (HPLC), ~1 mg/mL
An antiapoptotic agent, it protects against NMDA receptor induced neuronal apoptosis,
extends cell survival in cells undergoing apoptosis following infection with viral vectors and abrogates apoptosis induced by hydrogen peroxide in T-cells. It is an inhibitor of adenine nucleotide translocase, which is a component of the mitochondrial permeability transition (MPT) pore complex. Bongkrekic acid prevents mitochondrial depolarization, swelling, rupture of mitochondrial outer membrane, and release of apoptogenic proteins such as cytochrome c. This phenomenon was observed during staurosporine induced apoptosis in Jurkat cells, in HepG2 undergoing apoptosis following TNF-α and ethanol.
B6179
Cyclic Pifithrin-α >95% (HPLC)
A stable analog of Pifithrin-α (Product Code P4359) with similar biological activities and lower cellular toxicity.
DMSO: 20 mg/mL
P4236
GNF-2 ≥98% (HPLC), solid
GNF-2 belongs to a new class of Bcr-abl inhibitors. GNF-2 appears to bind to the myristoyl binding pocket, an allosteric site distant from the active site, stabilizing the inactive form of the kinase. It inhibits Bcr-abl phosphorylation with an IC
50
of 267 nM, but does not inhibit a panel of 63 other kinases, including native c-Abl, and shows complete lack of toxicity towards cells not expressing Bcr-Abl. GNF-2 shows great potential for a new class of inhibitor to study Bcr-abl activity and to treat resistant Chronic myelogenous leukemia (CML), which is caused the Bcr-Abl oncoprotein.
DMSO: >5 mg/mL
H
2
O: <2 mg/mL
G9420
MDL 28170 ≥95% (HPLC)
Potent cell permeable calpain I and II inhibitor; reduces capsaicin-mediated cell death in cultured dorsal root ganglion neurons. Reduced occurrence of apoptosis in H
2
O
2
and A23187 treated PC12 cells. γ-secretase-inhibitor.
DMSO: 26 mg/mL
H
2
O: insoluble
methanol: soluble
M6690
N
-Ethylmaleimide SigmaUltra, ≥98% (HPLC)
Augments currents from native M-channels in sympathetic neurons and acts as an opener for KCNQ2, KCNQ4 and KCNQ5 channels.
Sulfhydryl alkylating agent that inactivates NADP-dependent isocitrate dehydrogenase and many endonucleases.
95% ethanol: 50 mg/mL colorless to faint yellow, clear to slightly hazy
E1271
N
-Ethylmaleimide crystalline, ≥98% (HPLC)
Augments currents from native M-channels in sympathetic neurons and acts as an opener for KCNQ2, KCNQ4 and KCNQ5 channels.
Sulfhydryl alkylating agent that inactivates NADP-dependent isocitrate dehydrogenase and many endonucleases.
E3876
NS3694 ≥98%, solid
Inhibitor of apoptosome formation.
DMSO: 22 mg/mL, soluble
H
2
O: <5 mg/mL, insoluble
N7787
NSCI ≥97% (HPLC), solid
NSCI is a nonpeptide caspase 3 selective inhibitor.
DMSO: >10 mg/mL
H
2
O: insoluble
N1413
Necrostatin-1 ≥98% (HPLC), solid
Necrostatin-1 is an inhibitor of necroptosis (non-apoptotic cell death pathway).
DMSO: >10 mg/mL
N9037
Pifithrin-α ≥95% (HPLC), powder
Pifithrin-α is a reversible inhibitor of p53-mediated apoptosis and p53-dependent gene transcription such as cyclin G, p21/waf1, and mdm2 expression. Pifithrin-α enhances cell survival after genotoxic stress such as UV irradiation and treatment with cytotoxic compounds including doxorubicin, etopoxide, paclitaxel, and cytosine-β-D-arabinofuranoside. Pifithrin-α protects mice from lethal whole body γ-irradiation without an increase in cancer incidence. The protective effect is not seen in p53-null mice or cells expressing a dominant negative mutant of the p53 gene. Protection is conferred by the transient expression of p53 in p53-deficient cell lines.
DMSO: 20 mg/mL
P4359
Pifithrin-μ ≥97% (HPLC), solid
Pifithrin-μ is an inhibitor of p53 binding and anti-apoptotic, which directly inhibits p53 binding to mitochondria as well as to Bcl-xL and Bcl-2 proteins. PFTμ rescues cells from lethal γ-irradiation-induced cell death. Because pifithrin-μ shuts down only the p53-mitochondrial pathway without affecting the transcriptional functions of p53, it is superior to pifithrin-α.
DMSO: >10 mg/mL
H
2
O: <2 mg/mL
P0122
R5C3 ≥97% (HPLC), solid
MDM2 inhibitor, 2-phenoxybenzoyl-tryptophan derivative. Reported as a novel probe for high throughput fluorescence polarization binding assay. Useful in drug screening for small molecule inhibitors of MDM2-binding to p53.
DMSO: 18 mg/mL
R7529
S-15176 difumarate salt ≥98% (HPLC), solid
Antioxidant and anti-ischemic agent. Also inhibits mitochondrial permeability transition, prevents the early step in apoptosis by preventing collapse of the electrochemical gradient across the mitochondrial membrane. IC
50
for
in vitro
lipid peroxidation is 0.3 μM. IC
50
for carnitine palmitoyltransferase (CPT-1) in heart homogenate is 16.8 μM. The shift from fatty acid to glucose oxidation may contribute to anti-ischemic effect.
DMSO: 16 mg/mL, soluble
H
2
O: insoluble
S5944
Site Use Terms
|
Terms and Conditions of Sale
|
Privacy
|
Copyrights © 2008 Sigma-Aldrich Co. All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission. Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich, Inc.